Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph T Opferman

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Genes & Development|June 22, 2013
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunctionXi Wang, Madhavi Bathina, John Lynch, et al.
European Journal of Medicinal Chemistry|January 7, 2019
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agentsTaotao Ling, Julie Maier, Sourav Das, et al.
Chemistry & Biology|September 25, 2012
A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survivalNicole A Cohen, Michelle L Stewart, Evripidis Gavathiotis, et al.
The EMBO Journal|December 9, 2010
MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated mannerMarc Germain, Angela P Nguyen, J Nicole Le Grand, et al.
Oncotarget|February 11, 2016
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell linesBrian Koss, Jeremy Ryan, Amit Budhraja, et al.
Blood|October 19, 2007
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survivalRobert T Woodland, Casey J Fox, Madelyn R Schmidt, et al.
Hepatology (Baltimore, Md.)|January 8, 2009
Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytesBinje Vick, Achim Weber, Toni Urbanik, et al.
Blood|January 29, 2021
Requirement for antiapoptotic MCL-1 during early erythropoiesisMeghan E Turnis, Ewa Kaminska, Kaitlyn H Smith, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 21, 2023
Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosisEusondia Arnett, Susanta Pahari, Chrissy M Leopold Wager, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Genes & Development|June 22, 2013
Deletion of MCL-1 causes lethal cardiac failure and mitochondrial dysfunctionXi Wang, Madhavi Bathina, John Lynch, et al.
European Journal of Medicinal Chemistry|January 7, 2019
Identification of substituted 5-membered heterocyclic compounds as potential anti-leukemic agentsTaotao Ling, Julie Maier, Sourav Das, et al.
Chemistry & Biology|September 25, 2012
A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survivalNicole A Cohen, Michelle L Stewart, Evripidis Gavathiotis, et al.
The EMBO Journal|December 9, 2010
MCL-1 is a stress sensor that regulates autophagy in a developmentally regulated mannerMarc Germain, Angela P Nguyen, J Nicole Le Grand, et al.
Oncotarget|February 11, 2016
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell linesBrian Koss, Jeremy Ryan, Amit Budhraja, et al.
Blood|October 19, 2007
Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survivalRobert T Woodland, Casey J Fox, Madelyn R Schmidt, et al.
Hepatology (Baltimore, Md.)|January 8, 2009
Knockout of myeloid cell leukemia-1 induces liver damage and increases apoptosis susceptibility of murine hepatocytesBinje Vick, Achim Weber, Toni Urbanik, et al.
Blood|January 29, 2021
Requirement for antiapoptotic MCL-1 during early erythropoiesisMeghan E Turnis, Ewa Kaminska, Kaitlyn H Smith, et al.
Breast Cancer Research and Treatment|October 31, 2018
Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancerSonia Vallet, Fengjuan Fan, Stefano Malvestiti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 21, 2023
Combination of MCL-1 and BCL-2 inhibitors is a promising approach for a host-directed therapy for tuberculosisEusondia Arnett, Susanta Pahari, Chrissy M Leopold Wager, et al.
Pageof 8